Rad Onc Twitter

  • Thread starter Thread starter deleted1002574
  • Start date Start date
This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
This conversation again? People worried about <1 percent of women having slightly more swollen breasts, by physician or self?
15 Fx has higher recurrence rates than 5 Fx in trial and also has higher cancer mortality rate than classical fractionation in recent trial.
You're telling me 15fx kills people? C'mon curb
 
I have one breast surgeon that does fantastic oncoplastic work and still manages to get a nice, well delineated, cluster of clips clinically where I would expect them to be for APBI. For low risk cases I still offer these patients APBI. I think her technique is more of a mastoxpexy though than a ton of "scrambling" of the tissue for lack of a better term.

However, some of the other breast surgeons leave me with no discernable cavity when they do their versions of oncoplastic reconstruction so I face your conundrum and practice like you as well - they typically get 40/15. Elderly patients not concerned with cosmesis that need whole breast I have integrated 26/5 into my regimen.
Even in “oncoplastic” cases (somehow I always, maybe rashly so, figure out where the tumor cavity is), and if low risk, you still have wide-open road to do “less than whole breast” tangents. Above someone was worried that 26/5 is worse side effects than 40/15; but yet when doing PBI I hope everyone uses a 26-30 Gy in 5f dose. That means the same minds who fret that 26/5 is worse than 40/15 for whole breast don’t fret when they apply the same (or more!) 26 Gy dose to a smaller volume. In other words, side effects aren’t just about dose it’s also about volume irradiated. The biggest statistical differences, by far, in terms of toxicity in breast RT trials are in big volume vs small volume irradiated… not in one hypofx regimen vs another.
 
RTOG 0415 - low risk prostate cancer treated with conventional fractionation vs moderate hypofractionation. Late G2-G3 GI/GU events were increased in the hypofrac arm (~1.4) but was still viewed as non-inferior.
The issue with 0415 may be the high urethral dose.
Very well explained here.

EQD2 (a/b=3 Gy) to the urethra was in 0415 about 8 Gy higher than in CHHiP.
 
Even in “oncoplastic” cases (somehow I always, maybe rashly so, figure out where the tumor cavity is), and if low risk, you still have wide-open road to do “less than whole breast” tangents.
The low dose bath with PBI to the non-PBI volume of the breast may be even more than one drop of Technetium-99 to the nipple...
 
1763592941434.png


Scheduled plan looks all green and fine, but I am gonna take the adapted one, cause I can.
Straight Gangsta.
 
Top